Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03579628
Title AsiDNA (a DNA Repair Inhibitor) Administered IntraVenously in Advanced Solid Tumors (DRIIV-1)
Acronym DRIIV-1
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Onxeo
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | BEL

Facility Status City State Zip Country Details
Institut Jules Bordet Bruxelles B-1000 Belgium Details
Grand Hôpital de Charleroi Charleroi 6000 Belgium Details
Centre Leon Berard Lyon 69008 France Details
Institut Curie Paris 75005 France Details
Institut Claudius Regaud Toulouse 31059 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field